Performance of the roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck

Cancer Cytopathology

Volumn 122, Issue 3, 2014, Pages 167-174

  Kerr, Darcy A ^a,b   Pitman, Martha B ^a,b   Sweeney, Brenda ^a,b   Arpin III, Ronald N ^a,b   Wilbur, David C ^a,b   Faquin, William C ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cobas; Cytology; Fine needle aspiration; Head and neck; Human papillomavirus; Polymerase chain reaction; Squamous cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HIGH RISK PATIENT; HISTOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; MIDDLE AGED; PRIMARY TUMOR; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; COBAS; COMPARATIVE STUDY; CYTOLOGY; EVALUATION STUDY; FINE-NEEDLE ASPIRATION; GENETICS; HEAD AND NECK; HEAD AND NECK TUMOR; METHODOLOGY; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; VIROLOGY; WART VIRUS;

VIRUS DNA;

COBAS; CYTOLOGY; FINE-NEEDLE ASPIRATION; HEAD AND NECK; HUMAN PAPILLOMAVIRUS; POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CARCINOMA, SQUAMOUS CELL; CYTOLOGICAL TECHNIQUES; DNA, VIRAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84899994199     PISSN: 1934662X     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21372     Document Type: Article

References (38)

1. Barwad A, Sood S, Gupta N, Rajwanshi A, Panda N, Srinivasan R. Human papilloma virus associated head and neck cancer: a PCR based study. Diagn Cytopathol. 2012;40:893-897
2. Jannapureddy S, Cohen C, Lau S, Beitler JJ, Siddiqui MT. Assessing for primary oropharyngeal or nasopharyngeal squamous cell carcinoma from fine needle aspiration of cervical lymph node metastases. Diagn Cytopathol. 2010;38:795-800
3. Krane JF. Role of cytology in the diagnosis and management of HPV-associated head and neck carcinoma. Acta Cytol. 2013;57: 117-126
4. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the united states. J Clin Oncol. 2008;26: 612-619 (Pubitemid 351264356)
5. Singhi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer. 2010;116:2166-2173
6. Solomides CC, Bibbo M, Wang ZX. Assessment of fine needle aspiration specimen adequacy for high-risk HPV detection and genotyping in oropharyngeal squamous cell carcinoma. Acta Cytol. 2012;56:196-198
7. Chung CH, Schwartz DL. Impact of HPV-related head and neck cancer in clinical trials: opportunity to translate scientific insight into personalized care. Otolaryngol Clin North Am. 2012;45:795-806
8. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24-35
9. Chaturvedi AK. Epidemiology and clinical aspects of HPV in head and neck cancers. Head Neck Pathol. 2012;6(suppl 1):S16-S24
10. Begum S, Westra WH. Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am J Surg Pathol. 2008;32:1044-1050
11. Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV titer, bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008;26:3128-3137
12. Nichols AC, Finkelstein DM, Faquin WC, et al. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer. Clin Cancer Res. 2010;16:2138-2146
13. Braakhuis BJ, Brakenhoff RH, Meijer CJ, Snijders PJ, Leemans CR. Human papilloma virus in head and neck cancer: the need for a standardised assay to assess the full clinical importance. Eur J Cancer. 2009;45:2935-2939
14. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008; 100:261-269 (Pubitemid 351480538)
15. Bishop JA, Guo TW, Smith DF, et al. Human papillomavirusrelated carcinomas of the sinonasal tract. Am J Surg Pathol. 2013; 37:185-192
16. Robinson M, Schache A, Sloan P, Thavaraj S. HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients. Head Neck Pathol. 2012;6(suppl 1):S83-S90
17. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX. Involvement of intact HPV16 E6=E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene. 2002;21:1510-1517 (Pubitemid 34226138)
18. Marur S, D'Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11:781-789
19. Bishop JA, Ma XJ, Wang H, et al. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6=E7 mRNA in situ hybridization method. Am J Surg Pathol. 2012;36:1874-1882
20. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709-720 (Pubitemid 30365531)
21. Fallai C, Perrone F, Licitra L, et al. Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status. Int J Radiat Oncol Biol Phys. 2009;75:1053-1059
22. Agrawal Y, Koch WM, Xiao W, et al. Oral human papillomavirus infection before and after treatment for human papillomavirus 16- positive and human papillomavirus 16-negative head and neck squamous cell carcinoma. Clin Cancer Res. 2008;14:7143-7150
23. Chuang AY, Chuang TC, Chang S, et al. Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. Oral Oncol. 2008;44:915-919
24. Begum S, Gillison ML, Nicol TL, Westra WH. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res. 2007;13:1186-1191 (Pubitemid 46424059)
25. Jakscha J, Zlobec I, Storck C, et al. The clinical impact of p16 status in fine-needle aspirates of cervical lymph node metastasis of head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol. 2013;270:661-667
26. Zhang MQ, El-Mofty SK, Davila RM. Detection of human papillomavirus- related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary. Cancer. 2008;114:118-123 (Pubitemid 351640791)
27. Bishop JA, Maleki Z, Valsamakis A, et al. Application of the hybrid capture 2 assay to squamous cell carcinomas of the head and neck: a convenient liquid-phase approach for the reliable determination of human papillomavirus status. Cancer Cytopathol. 2012; 120:18-25
28. Jordan RC, Lingen MW, Perez-Ordonez B, et al. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol. 2012;36:945-954
29. Lenhoff A. Five FDA-approved HPV assays. MLO Med Lab Obs. 2012;44:14-18
30. Nishino HT, Tambouret RH, Wilbur DC. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology. Cancer Cytopathol. 2011;119:219-227
31. Sweeney BJ, Grant HL, Rego M, Ring L, Faquin WC, Wilbur DC.Automated extraction of FFPE (formalin-fixed paraffin-embedded) tissue for head and neck HR-HPV (high-risk human papillomavirus) testing on the Roche cobas 4800 system. Paper presented at: American Society of Cytopathology 61st Annual Scientific Meeting, November 8-12, 2013; Orlando, Florida
32. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer. 2007;121:2465-2472 (Pubitemid 350022416)
33. Bishop JA, Westra WH. Human papillomavirus-related small cell carcinoma of the oropharynx. Am J Surg Pathol. 2011;35:1679-1684
34. Wadsworth B, Bumpous JM, Martin AW, Nowacki MR, Jenson AB, Farghaly H. Expression of p16 in sinonasal undifferentiated carcinoma (SNUC) without associated human papillomavirus (HPV). Head Neck Pathol. 2011;5:349-354
35. Cao D, Begum S, Ali SZ, Westra WH. Expression of p16 in benign and malignant cystic squamous lesions of the neck. Hum Pathol. 2010;41:535-539
36. Conscience I, Jovenin N, Coissard C, et al. P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas. Eur J Dermatol. 2006;16:518-522 (Pubitemid 44861826)
37. Kuo KT, Hsiao CH, Lin CH, Kuo LT, Huang SH, Lin MC. The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome. Mod Pathol. 2008;21:376-386
38. Taylor CR, Levenson RM. Quantification of immunohistochemistry- issues concerning methods, utility and semiquantitative assessment II. Histopathology. 2006;49:411-424 (Pubitemid 44401549)